UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term monitoring and risk assessment of N-nitrosamines in the finished water of drinking water treatment plants in South Korea

Environmental science and pollution research international, 2022, Vol.29 (3), p.3930-3943

2022

Volltextzugriff (PDF)

[환경] 저니토중 Polychlorinated Biphenyls(PCBs) 정량에 관한 연구

Punsŏk kwahak, 1999, Vol.12 (2), p.151-158

1999

Volltextzugriff (PDF)

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

The Lancet (British edition), 2023-01, Vol.401 (10373), p.269-280

2023

Volltextzugriff (PDF)

Prognostic significance of BLK expression in R-CHOP treated diffuse large B-cell lymphoma

Journal of Pathology and Translational Medicine, 2022, 56(5), , pp.281-288

2022

Volltextzugriff (PDF)

Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trials

Leukemia research, 2024-08, Vol.143, p.107542, Article 107542

2024

Volltextzugriff (PDF)

The Prognostic Implication of Inflammatory Factor-Based Scoring System in Diffuse Large B-Cell Lymphoma Patients in the Rituximab Era

Blood, 2017-12, Vol.130, p.4142-4142

2017

Volltextzugriff (PDF)

Pretreatment Nutritional Status and Cardiovascular Risk Factors Affect Survival of Diffuse Large B-Cell Lymphoma Patients Treated with Immunochemotherapy

Blood, 2017-12, Vol.130, p.2856-2856

2017

Volltextzugriff (PDF)

Long-Term Outcomes of Chronic Myeloid Leukemia Patients Who Lost Undetectable Molecular Residual Disease (UMRD) after Imatinib Discontinuation: Korean Imatinib Discontinuation Study (KIDS)

Blood, 2019-11, Vol.134 (Supplement_1), p.1643-1643

2019

Volltextzugriff (PDF)

The Impact of Early Molecular Response at 3 Months on Long-Term Survival Was Enhanced in the CP CML Patients Treated with Second-Generation Tyrosine Kinase Inhibitors

Blood, 2017-12, Vol.130, p.2873-2873

2017

Volltextzugriff (PDF)

Effectiveness of Convalescent Plasma Therapy in Severe or Critically Ill COVID-19 Patients: A Retrospective Cohort Study

Yonsei Medical Journal, 2021, 62(9), , pp.799-805

2021

Volltextzugriff (PDF)

Factors Affecting Family Values in Korea

The Journal of Humanities and Social sciences 21, 2023-02, Vol.14 (1), p.1779-1794

2023

Volltextzugriff (PDF)

Comprehensive analysis of mutation and expression based pathways in head and neck squamous cell carcinoma

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e18015-e18015

2018

Volltextzugriff (PDF)

Very Early Molecular Response at 1 Month Is a Predictor of the Outcome of Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Blood, 2017-12, Vol.130, p.1593-1593

2017

Volltextzugriff (PDF)

Characterization of ABL Compound Mutation Using Sanger and Subcloning Sequencing in Tyrosine Kinase Inhibitor Resistant Chronic Myeloid Leukemia

Blood, 2017-12, Vol.130, p.2864-2864

2017

Volltextzugriff (PDF)

Peripheral T cell lymphomas in elderly patients: a retrospective analysis from the Hematology Association of South East Korea (HASEK)

Annals of hematology, 2016-03, Vol.95 (4), p.619-624

2016

Volltextzugriff (PDF)

Long-Term Outcomes of Early CP CML Patients who have Achieved CCyR but Not MMR after 24 Months on Frontline Imatinib Therapy

Clinical lymphoma, myeloma and leukemia, 2017-10, Vol.17 (10), p.S16-S16

2017

Volltextzugriff (PDF)

Cytogenetic and Molecular Failure at 12 Months will be the Optimal Time Point for BCR-ABL1 Tyrosine Kinase Domain Mutation Analysis in Patients with Chronic Myeloid Leukemia: The Analysis Based on 2013 European LeukemiaNet Recommendation

Clinical lymphoma, myeloma and leukemia, 2017-10, Vol.17 (10), p.S17-S18

2017

Volltextzugriff (PDF)

Abstract 4518: Effects of a novel small molecule inhibitor of Wnt signal pathway, CWP232291, on primary tumor cells from patients with malignant hematologic diseases

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.4518-4518

2011

Volltextzugriff (PDF)

A Prospective Phase III Trial for Comparing Cyclophosphamide and Fludarabine Conditioning Regimen in Severe Idiopathic Aplastic Anemia

Biology of blood and marrow transplantation, 2020-03, Vol.26 (3), p.S249-S250

2020

Volltextzugriff (PDF)

Cluster Analysis of Emergency Medical Center Regional Use Patterns among Critically Ill Emergency Patients in Korea (2014-2018)

Crisis and Emergency Management: Theory and Praxis, 2023-01, Vol.13 (1), p.23-36

2023

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(20)

Sprache

Englisch
(19)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term monitoring and risk assessment of N-nitrosamines in the finished water of drinking water treatment plants in South Korea

[환경] 저니토중 Polychlorinated Biphenyls(PCBs) 정량에 관한 연구

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Prognostic significance of BLK expression in R-CHOP treated diffuse large B-cell lymphoma

Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trials

The Prognostic Implication of Inflammatory Factor-Based Scoring System in Diffuse Large B-Cell Lymphoma Patients in the Rituximab Era

Pretreatment Nutritional Status and Cardiovascular Risk Factors Affect Survival of Diffuse Large B-Cell Lymphoma Patients Treated with Immunochemotherapy

Long-Term Outcomes of Chronic Myeloid Leukemia Patients Who Lost Undetectable Molecular Residual Disease (UMRD) after Imatinib Discontinuation: Korean Imatinib Discontinuation Study (KIDS)

The Impact of Early Molecular Response at 3 Months on Long-Term Survival Was Enhanced in the CP CML Patients Treated with Second-Generation Tyrosine Kinase Inhibitors

Effectiveness of Convalescent Plasma Therapy in Severe or Critically Ill COVID-19 Patients: A Retrospective Cohort Study

Factors Affecting Family Values in Korea

Comprehensive analysis of mutation and expression based pathways in head and neck squamous cell carcinoma

Very Early Molecular Response at 1 Month Is a Predictor of the Outcome of Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Characterization of ABL Compound Mutation Using Sanger and Subcloning Sequencing in Tyrosine Kinase Inhibitor Resistant Chronic Myeloid Leukemia

Peripheral T cell lymphomas in elderly patients: a retrospective analysis from the Hematology Association of South East Korea (HASEK)

Long-Term Outcomes of Early CP CML Patients who have Achieved CCyR but Not MMR after 24 Months on Frontline Imatinib Therapy

Cytogenetic and Molecular Failure at 12 Months will be the Optimal Time Point for BCR-ABL1 Tyrosine Kinase Domain Mutation Analysis in Patients with Chronic Myeloid Leukemia: The Analysis Based on 2013 European LeukemiaNet Recommendation

Abstract 4518: Effects of a novel small molecule inhibitor of Wnt signal pathway, CWP232291, on primary tumor cells from patients with malignant hematologic diseases

A Prospective Phase III Trial for Comparing Cyclophosphamide and Fludarabine Conditioning Regimen in Severe Idiopathic Aplastic Anemia

Cluster Analysis of Emergency Medical Center Regional Use Patterns among Critically Ill Emergency Patients in Korea (2014-2018)

Suchergebnisse filtern